斯德哥尔摩2006-2020年生化确诊原发性甲状旁腺功能亢进症发病率与患病率上升
本研究基于瑞典斯德哥尔摩地区医疗数据库,纳入2006-2020年符合生化诊断标准的成人原发性甲状旁腺功能亢进症(PHPT)患者,发现年龄和性别调整发病率从2009年2.81/万人年升至2020年4.28/万人年,患病率从0.35/千人增至4.76/千人,但仅52%患者获临床诊断。
要点
- PHPT发病率与患病率显著上升,尤其≥70岁女性增幅最大。
- 仅52%生化确诊PHPT患者被临床诊断,提示诊断不足。
- 52%临床诊断患者接受甲状旁腺切除术,2013年后手术率稳定在每年4%-5%。
核心结论
- 基于大型医疗数据库,PHPT发病率和患病率显著上升,主要见于老年人,仅52%获临床诊断,需评估未诊断PHPT的长期临床负担。
研究设计与样本
- 基于人群的医疗队列研究,使用斯德哥尔摩CREAtinine Measurements数据库,覆盖三分之二成人人口及≥90%的65岁以上人群,纳入2006-2020年≥20岁符合生化诊断标准的PHPT患者。
主要发现
- 年龄和性别调整发病率从2009年2.81(95%CI 2.55-3.09)/万人年升至2020年4.28(95%CI 3.98-4.59)/万人年。
- 患病率从0.35/千人增至4.76/千人。
- 中位离子钙为1.39 mmol/L。
- 5346例(52%)获临床诊断,其中2800例(52%)接受甲状旁腺切除术,2013年后手术率稳定在每年4%-5%。
临床怎么用
- 内分泌科医生应关注老年人群PHPT筛查,提高临床诊断率。
- 对生化确诊PHPT患者评估手术指征,并了解近半数未获临床诊断的现状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Primary hyperparathyroidism (PHPT) prevalence appears to be rising, but substantial underdiagnosis persists. Accurate epidemiological data are needed, requiring population-based studies using strict biochemical criteria. OBJECTIVE: To determine incidence and prevalence of biochemically confirmed PHPT in Stockholm and characterize clinical recognition and surgical management. METHODS: This is a population-based healthcare cohort study using prespecified biochemical diagnostic algorithms in the Stockholm Region, Sweden, 2006-2020, using the Stockholm CREAtinine Measurements database which covers two-thirds of the adult population, including ≥90% of individuals ≥65 years. Adults aged ≥20 years with paired calcium and parathyroid hormone (PTH) measurements meeting biochemical criteria for PHPT were included. Individuals with estimated glomerular filtration rate ≤30 mL/min/1.73 m2, secondary hyperparathyroidism, or prior parathyroid surgery were excluded. Main outcome measures were the annual incidence rate and point prevalence of biochemically confirmed PHPT. RESULTS: Among 176 780 individuals contributing 578 227 PTH measurements, 10 190 patients fulfilling biochemical PHPT criteria were identified. Age- and sex-adjusted incidence rate increased from 2.81 (95% CI, 2.55-3.09) to 4.28 (95% CI, 3.98-4.59) per 10 000 person-years between 2009 and 2020, with the steepest increase among women aged ≥70 years. Prevalence increased from 0.35 to 4.76 per 1000 individuals. Median ionized calcium was 1.39 mmol/L. Clinical diagnosis of PHPT was documented in 5346 (52%) patients, of which 2800 (52%) underwent parathyroidectomy, with surgery rates stabilizing after 2013 at 4% to 5% annually. CONCLUSION: Using a large healthcare database, we observed substantially increasing PHPT incidence and prevalence, predominantly in older individuals. Only 52% received clinical diagnosis, underscoring the need for studies evaluating the long-term clinical burden of undiagnosed PHPT.
引用
- Thorsteinsson D, Granath F, Bränström R, et al. Increasing incidence and prevalence of biochemically confirmed primary hyperparathyroidism in Stockholm, 2006-2020. J Clin Endocrinol Metab. 2026. PMID: 41972345. doi:10.1210/clinem/dgag162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。